769 related articles for article (PubMed ID: 26675225)
1. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
Fangueiro JF; Veiga F; Silva AM; Souto EB
Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
[TBL] [Abstract][Full Text] [Related]
2. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in ocular drug delivery.
Achouri D; Alhanout K; Piccerelle P; Andrieu V
Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
[TBL] [Abstract][Full Text] [Related]
4. Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.
Mandal A; Bisht R; Rupenthal ID; Mitra AK
J Control Release; 2017 Feb; 248():96-116. PubMed ID: 28087407
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology in ocular drug delivery.
Sahoo SK; Dilnawaz F; Krishnakumar S
Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
[TBL] [Abstract][Full Text] [Related]
6. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
Shree D; Patra CN; Sahoo BM
Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
[TBL] [Abstract][Full Text] [Related]
7. Application of lipid nanoparticles to ocular drug delivery.
Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA
Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069
[TBL] [Abstract][Full Text] [Related]
8. Micelles: Promising Ocular Drug Carriers for Anterior and Posterior Segment Diseases.
Durgun ME; Güngör S; Özsoy Y
J Ocul Pharmacol Ther; 2020; 36(6):323-341. PubMed ID: 32310723
[TBL] [Abstract][Full Text] [Related]
9. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
Srinivasarao DA; Lohiya G; Katti DS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
[TBL] [Abstract][Full Text] [Related]
10. Recent patents on ocular drug delivery systems.
Conway BR
Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases.
Onugwu AL; Nwagwu CS; Onugwu OS; Echezona AC; Agbo CP; Ihim SA; Emeh P; Nnamani PO; Attama AA; Khutoryanskiy VV
J Control Release; 2023 Feb; 354():465-488. PubMed ID: 36642250
[TBL] [Abstract][Full Text] [Related]
12. Cyclodextrins and topical drug delivery to the anterior and posterior segments of the eye.
Loftsson T; Stefánsson E
Int J Pharm; 2017 Oct; 531(2):413-423. PubMed ID: 28391041
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
[TBL] [Abstract][Full Text] [Related]
14. Prodrugs and nanomicelles to overcome ocular barriers for drug penetration.
Gote V; Ansong M; Pal D
Expert Opin Drug Metab Toxicol; 2020 Oct; 16(10):885-906. PubMed ID: 32729364
[TBL] [Abstract][Full Text] [Related]
15. Ocular preparations: the formulation approach.
Kaur IP; Kanwar M
Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
[TBL] [Abstract][Full Text] [Related]
16. The prominence of the dosage form design to treat ocular diseases.
Campos PM; Petrilli R; Lopez RFV
Int J Pharm; 2020 Aug; 586():119577. PubMed ID: 32622806
[TBL] [Abstract][Full Text] [Related]
17. A review on recent drug delivery systems for posterior segment of eye.
Nayak K; Misra M
Biomed Pharmacother; 2018 Nov; 107():1564-1582. PubMed ID: 30257375
[TBL] [Abstract][Full Text] [Related]
18. Advances in ocular drug delivery.
Rawas-Qalaji M; Williams CA
Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
[TBL] [Abstract][Full Text] [Related]
19. Novel strategies for anterior segment ocular drug delivery.
Cholkar K; Patel SP; Vadlapudi AD; Mitra AK
J Ocul Pharmacol Ther; 2013 Mar; 29(2):106-23. PubMed ID: 23215539
[TBL] [Abstract][Full Text] [Related]
20. Patent perspectives for corticosteroids based ophthalmic therapeutics.
Suresh PK; Sah AK
Recent Pat Drug Deliv Formul; 2014; 8(3):206-23. PubMed ID: 25020063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
